德琪醫藥-B(06996.HK)確認業務經營正常 與翰森製藥(03692.HK)就中國希維奧合作或擴展至重要新適應症
德琪醫藥-B(06996.HK)公布,注意到公司股份價格及成交量於上周五(15日)出現異常波動,惟確認並不知悉相關價格及成交量異常波動的原因,或任何必須予以公布以避免造成公司證券虛假市場的資料,或任何需要根據證券及期貨條例予以披露的內幕消息。
公司確認目前業務經營保持正常,並且在公司最近宣布與翰森製藥(03692.HK)在中國就希維奧達成的商業合作夥伴關係的支持下,公司對其強大的臨床管線和希維爾的前景及對公司的長期發展都充滿信心。該合作為公司就希維奧可能擴展到重要新適應症正在進行的工作和潛力提供積極動力和重要補充。
截至昨日(17日),公司每個臨床管線項目都取得顯著的進展,包括在具有同類首創以及同類最佳潛力的全球權益管線資產中觀察到令人鼓舞的早期療效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.